Cargando…
Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with Sarcoidosis
The unknown etiology of sarcoidosis, along with the variability in organ involvement and disease course, complicates the effective treatment of this disease. Based on recent studies, the cellular inflammatory pathways involved in granuloma formation are of interest regarding possible new treatment o...
Autores principales: | Kraaijvanger, Raisa, Ambarus, Carmen A., Damen, Jan, van der Vis, Joanne J., Kazemier, Karin M., Grutters, Jan C., van Moorsel, Coline H. M., Veltkamp, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454122/ https://www.ncbi.nlm.nih.gov/pubmed/37628972 http://dx.doi.org/10.3390/ijms241612792 |
Ejemplares similares
-
Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease
por: Kraaijvanger, Raisa, et al.
Publicado: (2021) -
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
por: Kahlmann, Vivienne, et al.
Publicado: (2020) -
ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis Patients
por: Karakaya, Bekir, et al.
Publicado: (2022) -
Latent tuberculosis infection associates with cardiac involvement in patients with sarcoidosis
por: Beijer, Els, et al.
Publicado: (2020) -
The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?
por: Kraaijvanger, Raisa, et al.
Publicado: (2022)